Sign In
Buy WAT
$357.20
-1.05 (-0.293%)
At Close: Jun 23, 2026
News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas, and occupies up to 50% less bench space than o
Why Waters (WAT) is a Top Growth Stock for the Long-Term
10:50am, Wednesday, 28'th May 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
News Summary Enables measurements up to 2 days earlier for antibody titers for both clone selection and bioprocess monitoring.1 Provides up to 7x improvements in sensitivity with novel high efficiency
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio
08:00am, Wednesday, 21'st May 2025
MILFORD, Mass. , May 21, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and
Norwegian Cruise Line: Choppy Waters Ahead
09:59am, Monday, 19'th May 2025
Norwegian Cruise Line showed a very slight earnings decline in Q1, reflecting a capacity and occupancy decline, offset by a good net yield gain. Macroeconomic headwinds create a more turbulent outlook
Waters Corporation to Present at the Jefferies Global Healthcare Conference
11:00am, Friday, 16'th May 2025
MILFORD, Mass. , May 16, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Waters Corp's India business boosted by rush for weight-loss drugs
07:48am, Thursday, 15'th May 2025
U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers in India rushing to develop their versions of popular weight-loss drugs, a s
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
01:45pm, Wednesday, 07'th May 2025
WAT's first-quarter 2025 results reflect strong growth in the instruments and chemical segments, coupled with strong momentum in the industrial and pharma sectors.
Waters Corporation: Still A Hold After Q1 Earnings
04:20pm, Tuesday, 06'th May 2025
Waters Corporation's stock remains a "Hold" due to high valuation multiples, despite a 35% increase in stock price and improved business performance. The company reported solid Q1 2025 results, with 3
Waters Corporation (WAT) Q1 2025 Earnings Call Transcript
11:57am, Tuesday, 06'th May 2025
Waters Corporation (NYSE:WAT ) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Officer
Waters (WAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11:00am, Tuesday, 06'th May 2025
Although the revenue and EPS for Waters (WAT) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es
Waters (WAT) Q1 Earnings and Revenues Beat Estimates
08:10am, Tuesday, 06'th May 2025
Waters (WAT) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.21 per share a year ago.
Waters raises 2025 profit forecast on resilient demand for lab equipment
07:21am, Tuesday, 06'th May 2025
Waters raised its annual profit forecast on Tuesday, after reporting better-than-expected first quarter results due to higher demand for its medical instruments in Asia and the Americas.
News Summary Saves up to six months on compliant software validation in biopharmaceutical quality control.1 Reduces analysis time for biotherapeutic peptides and proteins by 20%.2 Enhances quality c
Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results
06:00am, Tuesday, 06'th May 2025
Highlights Strong start to the year as first quarter 2025 sales of $662 million landed at the high-end of guidance range; grew 4% as reported and 7% in constant currency Results led by instrument grow
